13F-HR filed by Cheyne Capital Management (UK) LLP
Cheyne Capital Management (UK) LLP filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-10-19, with 41 holding rows worth $213,199,000.
- Accession
- 0001140361-15-037930
- Filer
- CIK 1390457
- Filed
- 2015-10-19
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2015
A holdings report, 41 entries on the cover page, a total value of $213,199,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $213,199,000 with VALUE read as thousands by filing date, 13F file number 028-12483. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SUNOCO LP/SUNOCO FIN CORP | 86765K109 | COM UT REP LP | 368,500 | $36,138,000 | thousands by filing date | |
| CYTEC INDS INC | 232820100 | COM | 488,937 | $36,115,000 | thousands by filing date | |
| STRATEGIC HOTEL & RESORTS | 86272T106 | COM | 1,777,481 | $24,538,000 | thousands by filing date | |
| CABLEVISION SYS CORP | 12686C109 | CL A NY CABLVS | 746,549 | $24,229,000 | thousands by filing date | |
| PRECISION CASTPARTS CORP | 740189105 | COM | 76,500 | $17,575,000 | thousands by filing date | |
| ALTERA CORP | 021441100 | COM | 300,097 | $15,026,000 | thousands by filing date | |
| HOME PROPERTIES INC | 437306103 | COM | 187,903 | $14,050,000 | thousands by filing date | |
| SANDISK CORP | 80004CAD3 | CORPORATE OBLIG | 3,000,000 | $3,730,000 | thousands by filing date | principal |
| CLOVIS ONCOLOGY INC | 189464AB6 | NOTE 2.500% 9/1 | 2,000,000 | $3,325,000 | thousands by filing date | principal |
| CITRIX SYS INC | 177376AD2 | NOTE 0.500% 4/1 | 3,000,000 | $3,157,000 | thousands by filing date | principal |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 1,215,392 | $2,558,000 | thousands by filing date | |
| CRM 0.25 4/1/18 | 79466LAD6 | Bond 30/360P2 U | 2,000,000 | $2,438,000 | thousands by filing date | principal |
| Wells Fargo & Company | 949746101 | COM | 40,315 | $2,068,000 | thousands by filing date | |
| CEPHEID | 15670RAC1 | DBCV 1.250% 2/0 | 2,000,000 | $2,030,000 | thousands by filing date | principal |
| SYNCHRONOSS TECHNOLOGIES INC | 87157BAA1 | NOTE 0.750 8/1 | 2,000,000 | $2,020,000 | thousands by filing date | principal |
| NEKTAR THERAPEUTICS | 640268108 | COM | 172,306 | $1,889,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 220,618 | $1,863,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484MAA4 | NOTE 1.750% 6/1 | 2,000,000 | $1,826,000 | thousands by filing date | principal |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 10,150 | $1,682,000 | thousands by filing date | |
| CTRIP COM INTL LTD | 22943FAD2 | NOTE 1.250%10/1 | 1,500,000 | $1,625,000 | thousands by filing date | principal |
| RADNET INC | 750491102 | COM | 280,000 | $1,555,000 | thousands by filing date | |
| Prologis,Inc. | 74340W103 | COM | 39,268 | $1,528,000 | thousands by filing date | |
| DUKE REALTY CORP | 264411505 | COM NEW | 79,278 | $1,511,000 | thousands by filing date | |
| EBS 2.875 01/21 | 29089QAB1 | Bond 30/360P2 U | 1,250,000 | $1,415,000 | thousands by filing date | principal |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 109,000 | $1,228,000 | thousands by filing date | |
| TRAVELERS COMPANIES INC COM | 89417E109 | Stock | 11,000 | $1,095,000 | thousands by filing date | |
| MasterCard, Inc | 57636Q104 | COM | 12,000 | $1,081,000 | thousands by filing date | |
| RTI INTL METALS INC | 74973WAB3 | NOTE 1.625%10/1 | 1,000,000 | $1,046,000 | thousands by filing date | principal |
| EDGEWELL PERSONAL CARE CO | 28035Q102 | COM | 10,000 | $816,000 | thousands by filing date | |
| CRITEO S A SPONS ADS | 226718104 | ADR | 18,599 | $698,000 | thousands by filing date | |
| WMI HOLDINGS CORP | 92936P100 | COMMON | 220,000 | $573,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 30,000 | $502,000 | thousands by filing date | |
| INOVIO PHARMACEUTICALS INC | 45773H201 | COM NEW | 70,000 | $404,000 | thousands by filing date | |
| KINROSS GOLD CORP | 496902404 | COM | 215,000 | $371,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164AB0 | NOTE 2.750%12/0 | 500,000 | $347,000 | thousands by filing date | principal |
| BARRICK GOLD CORP | 067901108 | COM | 50,000 | $318,000 | thousands by filing date | |
| KINDER MORGAN INC DEL | 49456B119 | *W EXP 05/25/201 | 285,000 | $259,000 | thousands by filing date | principal |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 90,000 | $257,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 73,000 | $161,000 | thousands by filing date | |
| ONCOGENEX PHARMACEUTICALS IN | 68230A106 | COM | 62,000 | $137,000 | thousands by filing date | |
| QIHOO 360 TECHNOLOGY CO LTD | 74734MAB5 | NOTE 2.500% 9/1 | 4,000,000 | $15,000 | thousands by filing date | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-15-037930 | this filing | 2015-10-19 | acceptance time not in the bulk data set |